Development of a new type of middle-ear implant is proposed. The implant is intended to restore hearing in non-aerated ears by creating and permanently maintaining an air- or gas-filled space within the middle ear. The implant is intended to correct the conductive hearing loss that occurs in chronic otitis media and some cases of otitis media with effusion. The project is designed to optimize 1) materials and fabrication, 2) acoustic properties, and 3) physical barrier characteristics. Prototype devices will be implanted in cadaveric temporal bones and the acoustic response of the middle ear will be measured.

Proposed Commercial Applications

NOT AVAILABLE

Agency
National Institute of Health (NIH)
Institute
National Institute on Deafness and Other Communication Disorders (NIDCD)
Type
Small Business Technology Transfer (STTR) Grants - Phase I (R41)
Project #
1R41DC004456-01
Application #
6134468
Study Section
Special Emphasis Panel (ZRG1-IFCN-6 (02))
Program Officer
Luethke, Lynn E
Project Start
2000-05-01
Project End
2001-04-30
Budget Start
2000-05-01
Budget End
2001-04-30
Support Year
1
Fiscal Year
2000
Total Cost
$95,930
Indirect Cost
Name
Boston Medical Products, Inc.
Department
Type
DUNS #
City
Westborough
State
MA
Country
United States
Zip Code
01581